Abstract
The present invention generally relates to industrial microbiology, and specifically to the production of biochemical compounds, such as L-serine, L-tyrosine, mevalonate and their derivatives, and recombinant polypeptides using genetically modified microorganisms. More particularly, the present invention pertains to the decoupling of cell growth from production of biochemical compounds, such as L-serine, L-tyrosine, mevalonate and their derivatives, in a microorganism by down regulating the nucleotide biosynthesis in said microorganism.
Original language | English |
---|---|
IPC | C12N1/21; C12N15/63; C12N9/88; C12P13/22; C12P21/02; C12P7/42 |
Patent number | WO2018020012 |
Filing date | 01/02/2018 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 29/07/2016 |
Priority number | EP20160182046 |
Publication status | Published - 2018 |